Keywords: USA, Pay-for-delay, Patent settlements, FTC, GPhA

US FTC finds 60% rise in pharma pay-for-delay deals; flawed understanding says GPhA

Article | 05 May 2011

Pharmaceutical companies in the USA struck an unprecedented number of deals in fiscal year 2010 in which the manufacturers of branded ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in